Infusion Pumps – Market Insights – United States

The US infusion pump market will be primarily driven by the shift of infusion therapy into home and alternate care settings, supported by an aging population and rising chronic disease prevalence. Advances in automated insulin delivery will further support adoption over the forecast period. However, product recalls, stricter FDA requirements, and lower ASPs in alternate care settings will limit growth to some extent.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for infusion pumps in the US from 2019 through 2035.

Care delivery is migrating out of the hospital, and the segment mix is moving with it.

Which pump segments are gaining from the shift to alternate care settings, and which are losing?

How does the pricing gap between hospitals and alternate care settings affect segment revenue growth?

Safety events and regulatory scrutiny remain a structural constraint on the market.

How have recent recalls affected purchasing behavior and brand positioning across segments?

Which segment carries the greatest exposure to recall and regulatory risk?

Companies are employing various strategies to expand their market presence and boost sales.

Who are the leading players across different device markets?

What competitive advantages distinguish these top competitors?

Automated insulin delivery is redefining the addressable patient base.

What effect will expansion into type 2 diabetes have on insulin pump adoption?

How is the balance between patch pumps and conventional pumps expected to evolve?